All contributors
Onconephrology contributor
Abudayyeh, Ala
Primarily Anticancer drug nephrotoxicity
32
Clinical papers
1,445
Citations (iCite)
3 / 14
First / senior author
2014–2026
Active years
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
Anticancer drug nephrotoxicity17
Checkpoint-inhibitor kidney injury15
Onco-nephrology (general)8
Myeloma cast nephropathy4
MGRS & paraprotein kidney disease2
Cellular therapy renal effects2
Agents they study
Catalog agents whose clinical kidney literature lists Abudayyeh among the leading contributors.
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers (regenerated 2026-07-08). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.